ANDA 76450, held by Actavis Elizabeth. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 76450 (Metformin Hydrochloride), held by Actavis Elizabeth, was first approved by FDA on Oct 1, 2004, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 1, 2004 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metformin Hydrochloride500MG · tablet, extended release;oral | Metformin Hydrochloride | Discontinued |
| Aug 11, 2026 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jul 14, 2026 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jul 14, 2026 | Supplement 10Labeling · Standard review | Approved | None posted |
| Oct 1, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters